[ad_1] Cipla Ltd. shares jumped over 10% in early trading on Thursday after the USFDA classified its Goa facility as a “Voluntary Action Indicated” (VAI) status. The Goa facility was earlier re-inspected by the regulator between June 10 – June 21, 2024, post which, six observations were issued. The VAi status now paves the way […]
Cipla shares fall to a five-month low, among top Nifty 50 losers after Q2 results – CNBC TV18
[ad_1] Shares of Cipla Ltd. are down as much as 4% on Wednesday, October 30 and are the top losers on the Nifty 50 index. The fall in the stock price comes after analysts cut their target price on the stock following the company’s September quarter results that were reported during market hours on Tuesday. […]
Cipla Q2 Results: US sales meet expectations; Growth led by EMs, South Africa – CNBC TV18
[ad_1] Drugmaker Cipla Ltd. reported a 15% year-on-year jump in net profit at ₹1,303 crore, which was higher than CNBC-TV18’s poll of ₹1,250 crore. The company posted a profit of ₹1,131 crore in the same period a year ago. Cipla’s topline was in-line with estimates of ₹7,041.6 crore. The company’s revenue from operations came in […]